Lupin plans $250-million pharma plant in Florida, shares jump; Anil Singhvi gives 'buy' call

Lupin Share Price Today: Shares of Lupin Ltd. rose over 3 per cent on Thursday, October 9, after the Indian pharmaceutical major announced plans to set up a high-tech manufacturing facility in Coral Springs, Florida. The plant aims to expand U.S.-based production of critical respiratory medicines and strengthen the supply chain for essential drugs.

Lupin will invest $250 million over the next five years in research, infrastructure, and capital expenditures. The facility is expected to produce more than 25 key respiratory medicines, including albuterol inhalers for children with asthma and U.S. service members, ensuring medicine security and accessibility across the country.

The project is also set to create over 200 long-term skilled jobs in Broward County by 2030, boosting the local economy. The move comes as U.S. tariffs on branded and patented drugs remain in effect, with exemptions for companies that manufacture domestically, providing Lupin a strategic advantage.

Add Zee Business as a Preferred Source

Anil Singhvi gives 'Buy' call on Lupin

Anil Singhvi recommends buying Lupin Futures, noting the company’s plan to build a pharma manufacturing plant in Florida with an estimated investment of Rs 2,220 crore. The stock has a stop loss at Rs 1,885, with target prices at Rs 1,935 and Rs 1,948.